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Following a highly influential paper by de Silva,1 there have
been many reported examples of individual molecular logic gates,2
and molecular equivalents of even more complex digital designs
were presented in recent years, such as half adder,3 half-subtractor4
and multiplexer.5 Nevertheless, the unresolved issues of individual
addressability and input-output heterogeneity remain to be im-
portant handicaps, making molecular logic gates very difficult to
integrate for the implementation of more advanced digital opera-
tions. However, in recent years, there have been important advances
toward finding practicality in molecular logic gates, such as,
identification tags for small objects,6 molecular keypad lock,7
laboratory on molecule,8 and pro-drug activation.9 RNA-based logic
devices were also shown to be promising in vitro, yielding
fluorescent proteins,10 or potentially important DNA antisense drug
sequences as outputs.11
In this Communication, we will put forward the idea that in
essence, a comparison between the silicon-based digital electronics
and “chemical” logic gates is mostly unfair, chemical logic systems
are inherently more capable than they are given credit for, and the
potential of the chemical logic gates is yet largely untapped. The
chemical logic gates and the biomolecules in living systems,
including ourselves, speak the same language. It may be challenging
to integrate two molecular logic gates; however, they can be easily
integrated into the control processes of healthy or pathological
biochemistry.
Photodynamic therapy is a noninvasive methodology used for
the treatment malignant tumors and age related macular degenera-
tion. The treatment requires a combined application of red to near
IR light and a sensitizer. The cytotoxic agent thus produced within
the target region is singlet oxygen.
A few years ago, O’Shea published12 a report, where it was
shown that singlet oxygen generation rate could be modulated by
pH. This effect is directly related to PET efficiency; excited-state
molecules can relax through a number of different pathways
including two competing processes, intersystem crossing and
photoinduced electron transfer. Blocking of PET process by
protonation of the amine PET donor, shuts down one channel of
deactivation, and thus enhances intersystem crossing efficiency and
the rate of singlet oxygen generation.
Recent works by Nagano13 and us14 have demonstrated that
appropriately decorated bodipy15 dyes can be very efficient genera-
tors for singlet oxygen, and thus act as satisfactory photodynamic
agents. As a bonus, the dyes synthesized in our laboratory absorbed
very strongly at 660 nm which is considered to be well within the
therapeutic window of mammalian tissue. We are aware of the fact
that PET process can be manipulated by a large variety of
modulators other than pH: cations, anions, carbohydrates, phos-
phates, among others.16 So, combining our earlier experience in
molecular logic gates and rational design of photodynamic agents,
we proposed a photodynamic therapy agent that would release
singlet oxygen at a much larger rate when two cancer related cellular
parameters are above a threshold value within the same spatio-
temporal coordinates. Thus, the proposed logic gate would be
actually an AND logic gate, the output of which would be singlet
oxygen. Following a survey of the relevant literature for cancer
related cellular parameters, we decided that Na+ and H+ concentra-
tions (pH) could be very promising targets. In the tumor tissues,
the pH can be quite acidic, especially in the intracellular large acidic
vacuoles (LAV) it can drop below 4,17 and intracellular sodium
ion concentration is also significantly higher (up to three times)
than normal tissues.18 Thus, in the proposed logic system the
chemical inputs are Na+ and H+. The molecular system is in fact
an automaton which is to seek higher concentration of both
hydrogen and sodium ions, and release the cytotoxic agent (singlet
oxygen) only when both concentrations are high. The design for
the automaton includes the following elements: (i) strong long
wavelength absorption, preferably beyond 650 nm; 3,5-distyryl
substituted bodipy dyes are useful in this regard with typical
absorption peaks ranging from 630-720 nm; (ii) an acid sensitive
absorption peak; we reasoned this could be best achieved by
incorporating dimethylaminostyryl or pyridylethenyl moieties; (iii)
in order to modulate PET efficiency and intersystem crossing
efficiency which is directly related to the PET process we utilized
a crown-ether-based PET modulator which is only sensitive to
sodium but not to hydrogen ions. With these design considerations,
we set out for the synthesis of compound 1.
The synthesis starts with the formylation of benzo[15]-crown-5.
Then, using standard procedures and the resulting aldehyde, together
with 2,4-dimethylpyrole a bodipy dye was obtained. To facilitate
intersystem crossing, 2 and 6 positions of the boradiazaindacene
ring system were iodinated with iodic acid-iodine mixture.13 Acid
sensitivity conferring pyridyl groups were appended by a 2-fold
Knoevenagel reaction of 3 and 5 methyl substituents on the bodipy
core and 4-pyridylcarboxyaldehyde.19
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Spectral characteristics and singlet oxygen generation capacity
of compound 1 were studied in acetonitrile. When a small aliquot
of TFA was added to acetonitrile solution of 1, a red shift in the
absorption spectra was observed moving the absorption peak value
from 630 to 660 nm (Figure 1). We have also demonstrated that
this shift is produced only when acid was added, and even large
sodium concentrations did not cause any spectral shifts. The
excitation source of our choice was an LED array with peak
irradiation at 660 nm. This means that the dye 1 would be most
efficiently excited under acidic conditions to generate singlet
oxygen, because only when pyridine groups are protonated, does
the compound become strongly absorbing at 660 nm as a result of
protonation-induced bathochromic shift.
Relative rates of singlet oxygen generation were determined using
1,3-diphenyl-isobenzofuran as a trap molecule. The results are
shown in Table 1. Thus, using 660 nm LED source maximum rate
of singlet oxygen generation were observed when both TFA and
Na+ ions were present. When neither TFA nor Na+ were present
or when only TFA was present, a significantly lower rate of
production is in effect. Na+ alone results in a somewhat higher
rate than the reference state (both inputs ) 0) demonstrating strong
reciprocal relationship between PET and intersystem crossing
processes at least for this molecule. This experimental results are
in accordance with AND logic operation. We also wanted to
eliminate nonspecific ionic strength related effects as a cause for
the faster rate of singlet oxygen generation in 1.0 mM Na+ solutions.
When Cs+ salt (chloride) was added at the same concentration
instead of Na+, the rate of singlet oxygen production was not altered,
it was the same as the reference rate.
Cs+ does not have a particular affinity for the smaller crown
ether moiety, so Cs+ addition is not expected to modulate PET
process.
In conclusion, the compound 1 is a prototypical example of an
automaton which would release its lethal weapon following an
evaluation of the endogenous cellular parameters for signs of
disease, and when necessary and sufficient conditions are met. This
prototype also points to the direction of further development;
incorporation of additional functional units which modulate singlet
oxygen generation efficiency could result in therapeutic agents with
a very high level of selective delivery potential. The notion of
molecular logic gates assisted us in the design of this particular
PDT agent and it is very likely molecular medicine could be the
first niche application of molecule-based logic gates. The molecular
automaton described here, combines sensing, computing, and
actuating functions within a single molecule. While we appreciate
the fact that the acidity and ion concentrations used in this proof-
of-principle study is too high to have direct biological consequence,
this work demonstrates how, when liberated from the boundaries
of silicon-dominated digital world, we might start to appreciate the
true potential of the molecular electronics.
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Figure 1. Spectral changes in acetonitrile solution of the compound 1 (2.0
× 10-5 M) in response to added modulators: (a) no added modulators, (b)
Na+, (c) TFA, (d) Na+ and TFA. The vertical line corresponds to the
wavelength (660 nm) of LED excitation in the singlet oxygen generation
experiments.




0 0 low (1.0)
1 0 low (2.9)
0 1 low (1.0)
1 1 high (6.1)
a For Na+ input ) 1, sodium ion concentration was set to 1.0 mM.
For H+ input ) 1, TFA concentration was set to 0.1 mM. b Relative
rates of singlet oxygen production in isopropyl alcohol was determined
by the degradation of the trap molecule 1,3-diphenylisobenzofuran (100
µM).
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